Emergence of SARS-CoV-2 variants in the world: how could this happen? A Parra-Lucares, P Segura, V Rojas, C Pumarino, G Saint-Pierre, L Toro Life 12 (2), 194, 2022 | 53 | 2022 |
Clinical efficacy of SARS-CoV-2 vaccination in hemodialysis patients R Torres, L Toro, ME Sanhueza, E Lorca, M Ortiz, J Pefaur, R Clavero, ... Kidney International Reports 7 (10), 2176-2185, 2022 | 32 | 2022 |
Humoral immune response of BNT162b2 and CoronaVac vaccinations in hemodialysis patients: a multicenter prospective cohort R Clavero, A Parra-Lucares, G Méndez-Valdés, E Villa, K Bravo, ... Vaccines 10 (9), 1542, 2022 | 17 | 2022 |
Cardiomyopathy associated with anti-SARS-CoV-2 vaccination: what do we know? A Parra-Lucares, L Toro, S Weitz-Muñoz, C Ramos Viruses 13 (12), 2493, 2021 | 17 | 2021 |
High plasma levels of fibroblast growth factor 23 are associated with increased risk of COVID-19 in end-stage renal disease patients on hemodialysis: results of a prospective … L Toro, L Michea, A Parra-Lucares, G Mendez-Valdes, E Villa, I Bravo, ... Toxins 15 (2), 97, 2023 | 7 | 2023 |
New opportunities in heart failure with preserved ejection fraction: from bench to bedside… and back A Parra-Lucares, E Romero-Hernández, E Villa, S Weitz-Muñoz, ... Biomedicines 11 (1), 70, 2022 | 3 | 2022 |
Rabdomiólisis como presentación inicial de COVID-19. Caso Clínico L Toro, P Zamorano, A Frías, A Parra-Lucares, MF Silva, P Almeida, ... Revista médica de Chile 149 (5), 796-802, 2021 | 3 | 2021 |
High Plasma Levels of Fibroblast Growth Factor 23 Are Associated with Increased Risk of COVID-19 in End-Stage Renal Disease Patients on Hemodialysis: Results of a Prospective … L Toro, L Michea, A Parra-Lucares, G Mendez-Valdes, E Villa, I Bravo, ... DOI: https://doi. org/10.3390/toxins15020097, 2023 | 2 | 2023 |
Clinical Implications of High-Sensitivity Troponin Elevation Levels in Non-ST-Segment Elevation Myocardial Infarction Patients: Beyond Diagnostics C Bravo, G Vizcarra, A Sánchez, F Cárdenas, JP Canales, H Ugalde, ... Diagnostics 14 (9), 893, 2024 | | 2024 |
WCN24-923 HIGH FIBROBLAST GROWTH FACTOR 23 LEVELS INCREASE RISK OF SARS-COV-2 INFECTION AND MORTALITY IN END-STAGE CHRONIC KIDNEY DISEASE ON HEMODIALYSIS: A 3-YEAR FOLLOW-UP … L Toro, L Michea, A Parra-Lucares, G Mendez-Valdes, E Villa, I Bravo, ... Kidney International Reports 9 (4), S206, 2024 | | 2024 |
WCN24-653 MALNUTRITION IS A RISK FACTOR FOR LOWER HUMORAL IMMUNE RESPONSE AFTER ANTI-SARS-COV-2 VACCINATION IN PATIENTS ON HEMODIALYSIS: RESULTS OF A MULTI-CENTER PROSPECTIVE … L Toro, R Clavero, A Parra-Lucares, G Mendez-Valdes, E Villa, K Bravo, ... Kidney International Reports 9 (4), S204, 2024 | | 2024 |
A Combined Biomarker That Includes Plasma Fibroblast Growth Factor 23, Erythropoietin, and Klotho Predicts Short-and Long-Term Morbimortality and Development of Chronic Kidney … L Toro, V Rojas, C Conejeros, P Ayala, A Parra-Lucares, F Ahumada, ... Biomolecules 13 (10), 1481, 2023 | | 2023 |
Tic-Tac: A Translational Approach in Mechanisms Associated with Irregular Heartbeat and Sinus Rhythm Restoration in Atrial Fibrillation Patients A Parra-Lucares, E Villa, E Romero-Hernandez, G Mendez-Valdes, ... International Journal of Molecular Sciences 24 (16), 12859, 2023 | | 2023 |
Paciente de 30 años con infarto agudo al miocardio e infección por SARS-CoV-2, presentación inhabitual de Covid-19. Caso clínico S Weitz-Muñoz, A Parra-Lucares, F Ihl, C Ramos, E Chaigneau, ... Revista médica de Chile 148 (12), 1848-1854, 2020 | | 2020 |
COVID-19 infection presenting as a myocardial infarction. Report of one case Paciente de 30 años con infarto agudo al miocardio e infección por SARS-CoV-2, presentación … S Weitz-Munoz, A Parra-Lucares, F Ihl, C Ramos, E Chaigneau, ... Sociedad Medica de Santiago, 2020 | | 2020 |
Epidemia de COVID-19 en Chile: impacto en atenciones de Servicios de Urgencia y Patologías Específicas L Toro Cabrera, A Parra Lucares, M Alvo Abodovsky Sociedad Médica Santiago, 2020 | | 2020 |